FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096221134> ?p ?o ?g. }

• W3096221134 endingPage "386" @default.
• W3096221134 startingPage "376" @default.
• W3096221134 abstract "Diffuse midline gliomas (DMGs), including diffuse intrinsic pontine gliomas (DIPGs), have a dismal prognosis, with less than 2% surviving 5 years postdiagnosis. The majority of DIPGs and all DMGs harbor mutations altering the epigenetic regulatory histone tail (H3 K27M). Investigations addressing DMG epigenetics have identified a few promising drugs, including the HDAC inhibitor (HDACi) panobinostat. Here, we use clinically relevant DMG models to identify and validate other effective HDACi and their biomarkers of response.HDAC inhibitors were tested across biopsy-derived treatment-naïve in vitro and in vivo DMG models with biologically relevant radiation resistance. RNA sequencing was performed to define and compare drug efficacy and to map predictive biomarkers of response.Quisinostat and romidepsin showed efficacy with low nanomolar half-maximal inhibitory concentration (IC50) values (~50 and ~5 nM, respectively). Comparative transcriptome analyses across quisinostat, romidepsin, and panobinostat showed a greater degree of shared biological effects between quisinostat and panobinostat, and less overlap with romidepsin. However, some transcriptional changes were consistent across all 3 drugs at similar biologically effective doses, such as overexpression of troponin T1 slow skeletal type (TNNT1) and downregulation of collagen type 20 alpha 1 chain (COL20A1), identifying these as potential vulnerabilities or on-target biomarkers in DMG. Quisinostat and romidepsin significantly (P < 0.0001) inhibited in vivo tumor growth.Our data highlight the utility of treatment-naïve biopsy-derived models; establishes quisinostat and romidepsin as effective in vivo; illuminates potential mechanisms and/or biomarkers of DMG cell lethality due to HDAC inhibition; and emphasizes the need for brain tumor-penetrant versions of potentially efficacious agents." @default.
• W3096221134 created "2020-11-09" @default.
• W3096221134 creator A5004650824 @default.
• W3096221134 creator A5005741024 @default.
• W3096221134 creator A5008711275 @default.
• W3096221134 creator A5013549350 @default.
• W3096221134 creator A5014119310 @default.
• W3096221134 creator A5028123664 @default.
• W3096221134 creator A5034496059 @default.
• W3096221134 creator A5034544407 @default.
• W3096221134 creator A5041913264 @default.
• W3096221134 creator A5046523925 @default.
• W3096221134 creator A5048099013 @default.
• W3096221134 creator A5050535456 @default.
• W3096221134 creator A5051416013 @default.
• W3096221134 creator A5051662107 @default.
• W3096221134 creator A5059195008 @default.
• W3096221134 creator A5059868777 @default.
• W3096221134 creator A5066008961 @default.
• W3096221134 creator A5067633279 @default.
• W3096221134 creator A5079135058 @default.
• W3096221134 creator A5082847116 @default.
• W3096221134 creator A5084156179 @default.
• W3096221134 creator A5089680890 @default.
• W3096221134 creator A5089866615 @default.
• W3096221134 date "2020-11-01" @default.
• W3096221134 modified "2023-10-12" @default.
• W3096221134 title "Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models" @default.
• W3096221134 cites W1050308557 @default.
• W3096221134 cites W1986235688 @default.
• W3096221134 cites W1990980777 @default.
• W3096221134 cites W1991660464 @default.
• W3096221134 cites W1999952328 @default.
• W3096221134 cites W2001249814 @default.
• W3096221134 cites W2023351948 @default.
• W3096221134 cites W2027576483 @default.
• W3096221134 cites W2044060805 @default.
• W3096221134 cites W2051921450 @default.
• W3096221134 cites W2057718480 @default.
• W3096221134 cites W2058818049 @default.
• W3096221134 cites W2059916086 @default.
• W3096221134 cites W2062062519 @default.
• W3096221134 cites W2066788841 @default.
• W3096221134 cites W2090786177 @default.
• W3096221134 cites W2113056756 @default.
• W3096221134 cites W2124097252 @default.
• W3096221134 cites W2141444430 @default.
• W3096221134 cites W2158233796 @default.
• W3096221134 cites W2159271917 @default.
• W3096221134 cites W2169690426 @default.
• W3096221134 cites W2276336886 @default.
• W3096221134 cites W2366536035 @default.
• W3096221134 cites W2420857723 @default.
• W3096221134 cites W2538521050 @default.
• W3096221134 cites W2595257297 @default.
• W3096221134 cites W2606835938 @default.
• W3096221134 cites W2730446430 @default.
• W3096221134 cites W2758263587 @default.
• W3096221134 cites W2763504136 @default.
• W3096221134 cites W2802584573 @default.
• W3096221134 cites W2806622624 @default.
• W3096221134 cites W2884048968 @default.
• W3096221134 cites W2892432318 @default.
• W3096221134 cites W2896808622 @default.
• W3096221134 cites W2901803775 @default.
• W3096221134 cites W2907900842 @default.
• W3096221134 cites W2956654838 @default.
• W3096221134 cites W2976234797 @default.
• W3096221134 cites W2980438467 @default.
• W3096221134 cites W2981263082 @default.
• W3096221134 cites W2991430679 @default.
• W3096221134 cites W2993905360 @default.
• W3096221134 cites W2994743472 @default.
• W3096221134 cites W3014299867 @default.
• W3096221134 cites W4293529598 @default.
• W3096221134 doi "https://doi.org/10.1093/neuonc/noaa249" @default.
• W3096221134 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7992886" @default.
• W3096221134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33130903" @default.
• W3096221134 hasPublicationYear "2020" @default.
• W3096221134 type Work @default.
• W3096221134 sameAs 3096221134 @default.
• W3096221134 citedByCount "36" @default.
• W3096221134 countsByYear W30962211342020 @default.
• W3096221134 countsByYear W30962211342021 @default.
• W3096221134 countsByYear W30962211342022 @default.
• W3096221134 countsByYear W30962211342023 @default.
• W3096221134 crossrefType "journal-article" @default.
• W3096221134 hasAuthorship W3096221134A5004650824 @default.
• W3096221134 hasAuthorship W3096221134A5005741024 @default.
• W3096221134 hasAuthorship W3096221134A5008711275 @default.
• W3096221134 hasAuthorship W3096221134A5013549350 @default.
• W3096221134 hasAuthorship W3096221134A5014119310 @default.
• W3096221134 hasAuthorship W3096221134A5028123664 @default.
• W3096221134 hasAuthorship W3096221134A5034496059 @default.
• W3096221134 hasAuthorship W3096221134A5034544407 @default.
• W3096221134 hasAuthorship W3096221134A5041913264 @default.
• W3096221134 hasAuthorship W3096221134A5046523925 @default.
• W3096221134 hasAuthorship W3096221134A5048099013 @default.

• next